• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids

tetano

Editor, Senior Moderator
Front Immunol. 2016 Sep 29;7:399. eCollection 2016.
[h=1]HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids.[/h] Cox F[SUP]1[/SUP], Kwaks T[SUP]1[/SUP], Brandenburg B[SUP]1[/SUP], Koldijk MH[SUP]1[/SUP], Klaren V[SUP]1[/SUP], Smal B[SUP]1[/SUP], Korse HJ[SUP]1[/SUP], Geelen E[SUP]1[/SUP], Tettero L[SUP]1[/SUP], Zuijdgeest D[SUP]1[/SUP], Stoop EJ[SUP]1[/SUP], Saeland E[SUP]1[/SUP], Vogels R[SUP]1[/SUP], Friesen RH[SUP]1[/SUP], Koudstaal W[SUP]1[/SUP], Goudsmit J[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Interactions with receptors for the Fc region of IgG (FcγRs) have been shown to contribute to the in vivo protection against influenza A viruses provided by broadly neutralizing antibodies (bnAbs) that bind to the viral hemagglutinin (HA) stem. In particular, Fc-mediated antibody-dependent cellular cytotoxicity (ADCC) has been shown to contribute to protection by stem-binding bnAbs. Fc-mediated effector functions appear not to contribute to protection provided by strain-specific HA head-binding antibodies. We used a panel of anti-stem and anti-head influenza A and B monoclonal antibodies with identical human IgG1 Fc domains and investigated their ability to mediate ADCC-associated FcγRIIIa activation. Antibodies which do not interfere with sialic acid binding of HA can mediate FcγRIIIa activation. However, the FcγRIIIa activation was inhibited when a mutant HA, unable to bind sialic acids, was used. Antibodies which block sialic acid receptor interactions of HA interfered with FcγRIIIa activation. The inhibition of FcγRIIIa activation by HA head-binding and sialic acid receptor-blocking antibodies was confirmed in plasma samples of H5N1 vaccinated human subjects. Together, these results suggest that in addition to Fc-FcγR binding, interactions between HA and sialic acids on immune cells are required for optimal Fc-mediated effector functions by anti-HA antibodies.


[h=4]KEYWORDS:[/h] ADCC; CR6261; CR8033; CR9114; Fc-receptor; head-binding antibody; hemagglutinin; stem-binding antibody

PMID: 27746785 DOI: 10.3389/fimmu.2016.00399
[PubMed - in process] Free full text
 
Back
Top Bottom